How the mitochondrial protein CLPX helps developing red blood cells use iron and make heme
Regulation of erythroid iron metabolism by the CLPX unfoldase
This work looks at how a protein called CLPX helps developing red blood cells make heme and manage iron, which matters for conditions like anemia and porphyria.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11125782 on NIH RePORTER |
What this research studies
Scientists will study how CLPX in mitochondria controls the final steps of heme (the oxygen-carrying part of hemoglobin) production and how iron is handled during red blood cell maturation. They will use cellular and molecular lab experiments to measure porphyrin/heme intermediates, iron movement, and the effects of changing CLPX function. The team will combine biochemical assays, genetic manipulation, and analysis of erythroid cells to map how CLPX links heme synthesis to mitochondrial iron metabolism. Findings aim to clarify why disruptions in this pathway cause anemia, iron overload, or porphyria symptoms.
Who could benefit from this research
Good fit: People with inherited or acquired anemia, iron-overload disorders, or porphyria would be most relevant to the questions this research addresses.
Not a fit: Patients without blood, iron, or heme-related disorders are unlikely to see direct benefits from this basic laboratory research in the near term.
Why it matters
Potential benefit: If successful, this research could point to new targets or strategies to prevent or treat some forms of anemia, iron overload, and porphyria by restoring proper heme-iron balance in red blood cells.
How similar studies have performed: Prior laboratory work has shown CLPX affects heme synthesis in cells, but translating those findings into treatments is still new and unproven.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Yien, Yvette Y — University of Pittsburgh at Pittsburgh
- Study coordinator: Yien, Yvette Y
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.